These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16996403)

  • 61. Immunoadsorption therapy in Guillain-Barré syndrome.
    Hirai K; Kihara M; Nakajima F; Miyanomae Y; Yoshioka H
    Pediatr Neurol; 1998 Jul; 19(1):55-7. PubMed ID: 9682887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lipopolysaccharides of a Campylobacter coli isolate from a patient with Guillain-Barré syndrome display ganglioside mimicry.
    Bersudsky M; Rosenberg P; Rudensky B; Wirguin I
    Neuromuscul Disord; 2000 Mar; 10(3):182-6. PubMed ID: 10734265
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
    Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
    Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Guillain-Barré syndrome.
    Willison HJ; Jacobs BC; van Doorn PA
    Lancet; 2016 Aug; 388(10045):717-27. PubMed ID: 26948435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacterial infections in Guillain-Barré and Fisher syndromes.
    Yuki N; Koga M
    Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Guillain-Barre syndrome after myocardial infarction: a case report and literature review.
    Wen PY; Chen XW; Zhang M; Chu WZ; Wu HL; Ren C
    BMC Cardiovasc Disord; 2023 May; 23(1):226. PubMed ID: 37127573
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Guillain-Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis.
    Hadden RD; Gregson NA; Gold R; Willison HJ; Hughes RA
    J Neuroimmunol; 2001 Oct; 119(2):306-16. PubMed ID: 11585634
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M; Yuki N; Hirata K
    J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barré syndrome.
    Koga M; Yuki N; Hirata K; Morimatsu M; Mori M; Kuwabara S
    Neurology; 2003 May; 60(9):1514-8. PubMed ID: 12743241
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody].
    Ichikawa H; Susuki K; Yuki N; Kawamura M
    Rinsho Shinkeigaku; 2001 Aug; 41(8):523-5. PubMed ID: 11889840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Campylobacter genes responsible for the development and determinant of clinical features of Guillain-Barré syndrome].
    Yuki N
    Nihon Rinsho; 2008 Jun; 66(6):1205-10. PubMed ID: 18540372
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ophthalmoplegic Guillain-Barré syndrome: An independent entity or a transitional spectrum?
    Kim JK; Hong SK; Bae JS; Yoon BA; Park HT; Huh SY; Kim SJ; Kim JE; Kim DS
    J Clin Neurosci; 2016 Oct; 32():19-23. PubMed ID: 27436763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
    Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
    Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [A patient with Guillain-Barré syndrome in association with Campylobacter jejuni enteritis (PEN19:LIO7) in a patient with HLA-B52 antigen].
    Kaida K; Yuki N; Takahashi M; Kamakura K; Nagata N
    Rinsho Shinkeigaku; 1994 Jul; 34(7):733-5. PubMed ID: 7955736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Guillain-Barré syndrome and related diseases after influenza virus infection.
    Yamana M; Kuwahara M; Fukumoto Y; Yoshikawa K; Takada K; Kusunoki S
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e575. PubMed ID: 31355311
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Campylobacter jejuni enteritis and Guillain-Barre syndrome].
    Koga M; Yuki N
    Kansenshogaku Zasshi; 2003 Jun; 77(6):418-22. PubMed ID: 12872690
    [No Abstract]   [Full Text] [Related]  

  • 80. Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barré syndrome.
    Lange D; Aleksic S; Kassubek J; Vrvic MM; Kist M; Steinbrückner B; Mitova M
    Zentralbl Bakteriol; 1999 Oct; 289(4):429-44. PubMed ID: 10603661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.